AbbVie Inc. (NYSE:ABBV) Q4 2025 earnings call transcript

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript February 4, 2026 AbbVie Inc. beats earnings expectations. Reported ...
IG

Astrazeneca Full-Year 2025 Earnings Preview: 10 February 2026

AstraZeneca's full-year 2025 results are due on 10 February. Learn what investors should watch including Tagrisso sales, ...

Primary Sclerosing Cholangitis Market Outlook Highlights Rising Demand and Expanding Treatment Landscape Throughout the Forecast Period (2025-2034) | Delv…

DelveInsight's Primary Sclerosing Cholangitis Market Insights report includes a comprehensive understanding of current ...

Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

Amtagvi Response Rate with Two or Fewer Prior Lines of Therapy 73% Overall Disease Control RateSAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a ...
MarketBeat on MSN

Pfizer pops on Q4 results but this may be the catalyst that matters most

Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...
Marine Industry News

Saudi Arabia: the next marine investment frontier – or still a waiting game?

Chair of the GMBA, Richard Haws, discusses the potential and pitfalls of the marine market in Saudi Arabia. As the 12th largest country in the world, ...